TYK Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 2410?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders8,250,0002.22%
Public Companies10,468,5842.82%
Employee Share Scheme31,250,0008.43%
Institutions50,134,13113.5%
Private Companies103,417,72327.9%
General Public167,315,38045.1%

Dilution of Shares: 2410 only recently listed within the past 12 months


Top Shareholders

Top 12 shareholders own 54.88% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
27%
Tetranov Pharmaceutical (Zhengzhou) Co., Ltd.
100,000,000HK$2.0b0%no data
8.43%
TYK Medicines, Inc,ESOP
31,250,000HK$640.6m0%no data
2.98%
Ningbo Meishan Bonded Port Area Houyang Tongchi Investment Management Partnership (Limited Partnersh
11,035,614HK$226.2m0%no data
2.82%
Sichuan Huiyu Pharmaceutical Co., Ltd.
10,468,584HK$214.6m0%no data
2.59%
Jiangsu Addor Capital Results Innovation Venture Capital Fund (Limited Partnership)
9,600,000HK$196.8m0%no data
2.46%
Franklin Templeton Sealand Fund Management Co., Ltd.
9,139,200HK$187.4m0%0.76%
2.22%
Eric Hong Gu
8,250,000HK$169.1m0%no data
1.94%
Jiangsu Small and Medium Enterprises Development Fund (Limited Partnership)
7,200,000HK$147.6m0%no data
1.34%
Ningbo Meishan Bonded Port Area Houji Tongnuo Investment Management Partnership (Limited Partnership
4,951,317HK$101.5m0%no data
1.24%
Zhuzhou Guohai Guochuang Qianjin Pharmaceutical Venture Capital Partnership (Limited Partnership)
4,608,000HK$94.5m0%no data
0.97%
Jiangsu Talent Innovation Venture Capital Fund IV (Limited Partnership)
3,600,000HK$73.8m0%no data
0.92%
Houyang Tongchi Investment Management Partnership (Limited Partnership)
3,417,723HK$70.1m0%no data